BioNTech SE

NASDAQ: BNTX · Real-Time Price · USD
103.01
-1.78 (-1.70%)
At close: Aug 27, 2025, 3:59 PM
103.90
0.86%
After-hours: Aug 27, 2025, 07:53 PM EDT

BioNTech SE Income Statement

Financials in EUR. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
260.8M 182.8M 1.19B 1.24B 129.35M 188.7M 1.48B 895.3M 167.7M 1.28B 4.28B 3.46B 3.2B 6.37B 5.53B 6.09B 5.31B 2.05B
Cost of Revenue
76.4M 83.8M 243.5M 176.51M 60.1M 59.1M 179.1M 659.7M 536.3M 430M 693.3M 1.09B 1.16B 1.58B 854.7M 1.47B 1.08B 233.1M
Gross Profit
184.4M 99M 946.5M 1.07B 69.25M 129.26M 1.3B 235.6M -368.6M 847M 3.58B 2.37B 2.03B 4.79B 4.68B 4.62B 4.22B 1.82B
Operating Income
-501.1M -534.1M 148.6M 10.5M -703.04M -507.2M 526.2M 73.1M -563.3M 654.4M 3.29B 2.39B 2.21B 4.75B 4.7B 4.72B 4.2B 1.66B
Interest Income
100K 122.6M -66.4M 156.2M 167.7M 180.1M 120.4M 156.3M 152.4M 60.1M 38.8M 7.7M 1.5M 500K 300K 600K 304.99K 300K
Pretax Income
-402.7M -445.4M 301.2M 158.7M -809.88M -331.8M 663.2M 227.4M -412.2M 707.7M 3.17B 2.44B 2.32B 5.02B 4.71B 4.67B 4.02B 1.64B
Net Income
-386.6M -415.8M 259.5M 195.46M -811.89M -315.1M 457.9M 160.6M -190.4M 502.2M 2.28B 1.78B 1.67B 3.7B 3.17B 3.21B 2.79B 1.13B
Selling & General & Admin
137.4M 120.6M 132.1M 150.5M 184.73M 132.6M 149.4M 150.8M 140.8M 131.6M 137.5M 153.8M 148.1M 105.1M 145.9M 76.9M 59.8M 47.6M
Research & Development
509.1M 525.6M 611.8M 542.95M 587.56M 507.5M 577.8M 512.38M 372.58M 330.65M 485.89M 351.11M 405.8M 289.75M 273.02M 260.4M 201.1M 216.2M
Other Expenses
39M -13.1M 54M 361.95M n/a -4.4M 46.5M n/a n/a -13.6M 154.6M -8.3M -37.8M -5.6M -40.4M -279.9M -201.3M -70M
Operating Expenses
685.5M 633.1M 797.9M 1.06B 772.29M 643.87M 686.13M 153.7M 194.7M 118M 292.1M 145.5M 110.3M 99.5M 105.5M 57.4M 59.6M 193.8M
Interest Expense
3.4M 33.9M -7.4M 8M 7.3M 4.7M 18.9M 2M 1.3M 101.5M 2.1M 4.3M 5.8M 4.1M 3.4M 800K 178.83M 700K
Selling & Marketing Expenses
19.7M 13.7M 21.3M 18.1M 12.9M 15.6M 18M 14.4M 18.1M 12.2M 14.6M 12.8M 17.8M 14.3M 17.9M 10.5M 13.3M 8.7M
Cost & Expenses
761.9M 716.9M 1.04B 1.23B 832.39M 694.8M 881M 813.4M 731M 548M 985.4M 1.24B 1.27B 1.68B 960.2M 1.53B 1.14B 426.9M
Income Tax Expense
-16.1M -29.6M 41.7M -38.87M 2.01M -16.8M 205.3M 66.8M -221.8M 205.5M 893.9M 659.2M 647.3M 1.32B 1.55B 1.46B 1.24B 514.2M
Shares Outstanding (Basic)
241.63M 240.35M 240.28M 239.74M 237.73M 240.53M 237.73M 239.7M 239.77M 242.61M 242.93M 255.72M 259.22M 259.75M 244.47M 244.37M 244.06M 243.13M
Shares Outstanding (Diluted)
241.63M 240.35M 240.28M 244.57M 237.73M 240.53M 241M 239.7M 239.77M 244.98M 246.08M 255.72M 259.22M 259.75M 259.75M 260M 258.79M 256.97M
EPS (Basic)
-1.6 -1.73 1.08 0.83 -3.42 -1.31 1.88 0.69 -0.79 2.05 8.94 6.98 6.45 14.24 12.95 13.14 11.42 4.64
EPS (Diluted)
-1.6 -1.73 1.08 0.81 -3.42 -1.31 1.84 0.69 -0.79 2.03 8.83 6.98 6.45 14.24 12.19 12.35 10.77 4.39
EBITDA
-348.3M -368.7M 278.3M 211.1M -752.39M -290.5M 455.6M 278.57M -378.17M 809.9M 3.36B 1.97B 1.73B 5.12B 4.77B 4.55B 4.29B 1.63B
EBIT
-399.3M -411.5M 158.5M 166.7M -798.5M -329.03M 665.09M 236.07M -410M 736.7M 3.17B 2.45B 2.33B 5.09B 4.74B 4.67B 4.27B 1.64B
Depreciation & Amortization
51M 42.8M 119.8M 44.4M 50.15M 38.53M 33.6M 42.5M 31.83M 31.09M 27.64M 34.41M 33.71M 27.98M 26.15M 20.15M 16.67M 13.32M